Altshuler Shaham LTD Travere Therapeutics, Inc. Transaction History

Altshuler Shaham LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$20.94 - $30.01 $30,048 - $43,064	-1,435 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $5,383 - $6,976	-228 Reduced 13.71%	1,435 $37,000
Q4 2021 Feb 15, 2022	BUY	$24.34 - $31.17 $40,477 - $51,835	1,663 New	1,663 $52,000
Q2 2021 Aug 16, 2021	SELL	$14.11 - $26.4 $20,417 - $38,200	-1,447 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$23.37 - $31.77 $33,816 - $45,971	1,447 New	1,447 $36,000

184

89.8M

137K

181K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $899M
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.